Nanohale AG (FYB) | WebDisclosure

Basculer en Français

8302	Companies
115108	Keywords
55442	Articles
62528	Press releases

Home
Companies
Nanohale AG

BRIEF

published on 03/11/2024 at 07:35, 8 months 10 days ago

FYB201/Ranibizumab obtient l'approbation et son lancement est prévu dans la région MENA

Formycon AG MS Pharma Ranibizumab Région MENA Rétinopathies Diabétiques
PRESS RELEASE

published on 03/11/2024 at 07:30, 8 months 10 days ago

FYB201/Ranibizumab keeps gaining momentum with approvals and launches in the MENA region
Formycon AG and MS Pharma announce the approval and market launch of FYB201/Ranibizumab in the MENA region, with plans for commercialization in Saudi Arabia and other countries in 2024

MENA Region Formycon AG MS Pharma FYB201/Ranibizumab Biosimilar
PRESS RELEASE

published on 01/29/2024 at 22:15, 9 months 22 days ago

Gedeon Richter becomes strategic investor of Formycon via equity investment
Formycon AG announces strategic investment from Gedeon Richter, leading to a 9.08% equity takeover via cash capital increase of EUR 82.84 million. The investment will ensure high development pace and operational progress

Pharmaceutical Industry Formycon AG Gedeon Richter Equity Investment Biosimilars
PRESS RELEASE

published on 01/29/2024 at 22:10, 9 months 22 days ago

EQS-Adhoc: Formycon resolves on cash capital increase of EUR 82.84 million – all new shares were subscribed by Gedeon Richter as new strategic investor
Formycon AG resolves on EUR 82.84 million cash capital increase by issuing 1,603,877 new shares, all subscribed by Gedeon Richter as strategic investor. Proceeds for biosimilar pipeline development. New shares to be traded on Frankfurt Stock Exchange

Frankfurt Stock Exchange Formycon AG Cash Capital Increase Gedeon Richter Biosimilar Pipeline
PRESS RELEASE

published on 11/10/2023 at 06:30, 1 year ago

Formycon hosts conference call on nine-month figures 2023 and presents at further investor conferences
PRESS RELEASE

published on 10/10/2023 at 07:30, 1 year 1 month ago

Formycon Ranibizumab Biosimilar FYB201/CIMERLI®1 achieved 25% market share2 in the United States
PRESS RELEASE

published on 09/29/2023 at 07:30, 1 year 1 month ago

Formycon and Fresenius Kabi announce European Medicines Agency Submission Acceptance of the Marketing Authorization Application for FYB202, an Ustekinumab Biosimilar Candidate
PRESS RELEASE

published on 08/30/2023 at 07:30, 1 year 2 months ago

Formycon reports successful first half of 2023
PRESS RELEASE

published on 08/29/2023 at 07:30, 1 year 2 months ago

Formycon announces File Acceptance for FYB203, a biosimilar candidate to Eylea®1 (aflibercept), by the U.S. Food and Drug Administration (FDA)
PRESS RELEASE

published on 08/23/2023 at 07:30, 1 year 2 months ago

Formycon hosts conference call on financial and earnings position for H1 2023

Accesswire

Published on 11/21/2024 at 20:15, 1 hour 28 minutes ago

Woodland Park Zoo Awarded Transformative Grant to Advance Empathy for Animals
Published on 11/21/2024 at 20:10, 1 hour 33 minutes ago

For Us TV Productions, a Portfolio Company of Belle Bonica Luxe Corp., Invites BIPOC Filmmakers and Producers to Join Its Inclusive Streaming Platform
Published on 11/21/2024 at 20:00, 1 hour 43 minutes ago

Victory for New York Homeowners: Petroff Amshen LLP Blocks Lender’s Repeated Foreclosure Attempt
Published on 11/21/2024 at 19:25, 2 hours 18 minutes ago

Ibero Mining Reports Results From Deep Undercut Drill Hole At Miguel Vacas Mine
Published on 11/21/2024 at 17:35, 4 hours 8 minutes ago

1upHealth Ranked Number 43 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500(TM)

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 19:01, 2 hours 41 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/21/2024 at 18:36, 3 hours 7 minutes ago

Original-Research: Beaconsmind AG (von First Berlin Equity Research GmbH): BUY
Published on 11/21/2024 at 17:58, 3 hours 44 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/21/2024 at 17:51, 3 hours 51 minutes ago

LIGHTON announces highly successful IPO on Euronext Growth Paris.
Published on 11/21/2024 at 17:51, 3 hours 51 minutes ago

LIGHTON annonce le vif succès de son introduction en Bourse sur Euronext Growth Paris.

Les Echos

Published on 11/21/2024 at 06:58, 14 hours 45 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 14 hours 45 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 14 hours 45 minutes ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 1 day 1 hour ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 1 day 2 hours ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE